Mindfulness-assisted Psychedelic Therapy

PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 30, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2027

Conditions
Mental Health
Interventions
DRUG

Psilocybin plus mindfulness training

Participants will receive a single 25 mg dose of psilocybin under the supervision of study therapists. The psilocybin dosing session will take place approximately halfway through an 8-week mindfulness training course. The mindfulness training course will consist of weekly 2-hour classes with experienced mindfulness teachers; participants will be encouraged to practice mindfulness for 45 minutes per day between classes.

DRUG

Psilocybin

Participants will receive a single 25 mg dose of psilocybin under the supervision of study therapists.

Trial Locations (1)

90089

RECRUITING

Univeristy of Southern California Brain and Creativity Institute, Los Angeles

All Listed Sponsors
lead

University of Southern California

OTHER

NCT06233344 - Mindfulness-assisted Psychedelic Therapy | Biotech Hunter | Biotech Hunter